CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Pregnenolone

孕烯醇酮 杂质对照品Pregnenolone Impurities

22 个杂质条目22 impurity entries

本页汇总 孕烯醇酮 的 22 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 22 impurity reference standards of Pregnenolone. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 孕烯醇酮(Pregnenolone)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsDevelopment and validation of a quantitative proton NMR method for the analysis of pregnenolone
    Journal of pharmaceutical and biomedical analysis · 2023 · Schleiff M et al.  ·  PMID 36206694  ·  DOI
  2. 分析方法Analytical MethodsDetermination of 17alpha-hydroxypregnenolone sulfate and its application in diagnostics
    Steroids · 2007 · Vceláková H et al.  ·  PMID 17298837  ·  DOI
  3. 分析方法Analytical MethodsMeasurement of testosterone and pregnenolone in nails using gas chromatography-mass spectrometry
    Journal of chromatography. B, Biomedical sciences and applications · 2001 · Choi MH et al.  ·  PMID 11339293  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSynthesis of [3α-(3) H] 17α-hydroxy pregnenolone and [3α-(3) H] pregnenolone
    Journal of labelled compounds & radiopharmaceuticals · 2014 · Tian Y et al.  ·  PMID 24448740  ·  DOI

孕烯醇酮 —— 原料药与杂质对照品Pregnenolone — drug substance & impurities

共 23 个条目(含原料药本体)23 items incl. the drug substance
Pregnenolone structure
原料药 APIAPI
孕烯醇酮Pregnenolone
Pregnenolone
CAS No.145-13-1
Chemical FormulaC21H32O2
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 2 structure
2
孕烯醇酮杂质2Pregnenolone Impurity 2
Pregnenolone Impurity 2
CAS No.566-63-2
Chemical FormulaC21H32O2
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 3 structure
3
孕烯醇酮杂质3Pregnenolone Impurity 3
Pregnenolone Impurity 3
CAS No.1167-48-2
Chemical FormulaC21H32O4
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 4 structure
4
孕烯醇酮杂质4Pregnenolone Impurity 4
Pregnenolone Impurity 4
CAS No.1852-38-6
Chemical FormulaC21H32O5S·NaH
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 5 structure
5
孕烯醇酮杂质5Pregnenolone Impurity 5
Pregnenolone Impurity 5
CAS No.215996-51-3
Chemical FormulaC21H34O5S·C6H15N
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 6 structure
6
孕烯醇酮杂质6Pregnenolone Impurity 6
Pregnenolone Impurity 6
CAS No.974-23-2
Chemical FormulaC21H30O3
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 7 structure
7
孕烯醇酮杂质7Pregnenolone Impurity 7
Pregnenolone Impurity 7
CAS No.34209-81-9
Chemical FormulaC23H32O4
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 8 structure
8
孕烯醇酮杂质8Pregnenolone Impurity 8
Pregnenolone Impurity 8
CAS No.1176-21-2
Chemical FormulaC25H36O5
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 9 structure
9
孕烯醇酮杂质9Pregnenolone Impurity 9
Pregnenolone Impurity 9
CAS No.1434-54-4
Chemical FormulaC22H31NO2
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 10 structure
10
孕烯醇酮杂质10Pregnenolone Impurity 10
Pregnenolone Impurity 10
CAS No.1050-84-6
Chemical FormulaC21H32O5
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 11 structure
11
孕烯醇酮杂质11Pregnenolone Impurity 11
Pregnenolone Impurity 11
CAS No.566-61-0
Chemical FormulaC21H32O2
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 12 structure
12
孕烯醇酮杂质12Pregnenolone Impurity 12
Pregnenolone Impurity 12
CAS No.30626-96-1
Chemical FormulaC21H32O3
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 13 structure
13
孕烯醇酮杂质13Pregnenolone Impurity 13
Pregnenolone Impurity 13
CAS No.19037-28-6
Chemical FormulaC21H32O2
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 14 structure
14
孕烯醇酮杂质14Pregnenolone Impurity 14
Pregnenolone Impurity 14
CAS No.901-57-5
Chemical FormulaC21H34O2
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 15 structure
15
孕烯醇酮杂质15Pregnenolone Impurity 15
Pregnenolone Impurity 15
CAS No.131320-06-4
Chemical FormulaC21H33O5S-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 16 structure
16
孕烯醇酮杂质16Pregnenolone Impurity 16
Pregnenolone Impurity 16
CAS No.901-56-4
Chemical FormulaC21H34O2
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 17 structure
17
孕烯醇酮杂质17Pregnenolone Impurity 17
Pregnenolone Impurity 17
CAS No.114417-65-1
Chemical FormulaC23H33BrO3
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 18 structure
18
孕烯醇酮杂质18Pregnenolone Impurity 18
Pregnenolone Impurity 18
CAS No.1158830-87-5
Chemical FormulaC21H30O2
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 19 structure
19
孕烯醇酮杂质19Pregnenolone Impurity 19
Pregnenolone Impurity 19
CAS No.58701-45-4
Chemical FormulaC27H46O3Si
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 20 structure
20
孕烯醇酮杂质20Pregnenolone Impurity 20
Pregnenolone Impurity 20
CAS No.2381-45-5
Chemical FormulaC23H34O4
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 21 (Pregnenolone Isobutyrate) structure
21
孕烯醇酮杂质21 (异丁酸孕烯醇酮)Pregnenolone Impurity 21 (Pregnenolone Isobutyrate)
Pregnenolone Impurity 21 (Pregnenolone Isobutyrate)
CAS No.3109984-24-6
Chemical FormulaC25H38O3
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 22 structure
22
孕烯醇酮杂质22Pregnenolone Impurity 22
Pregnenolone Impurity 22
CAS No.116816-74-1
Chemical FormulaC22H31NO2
Purity>95%询价On request
10mg25mg50mg100mg
Pregnenolone Impurity 4-d4 structure
4-D4
孕烯醇酮杂质4-d4Pregnenolone Impurity 4-d4
Pregnenolone Impurity 4-d4
CAS No.1485492-21-4
Chemical FormulaC21H28D4O5S·NaH
Purity>95%询价On request

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

孕烯醇酮 —— 研究文献与合成路线Pregnenolone — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 孕烯醇酮 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Pregnenolone. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. The neurosteroid pregnenolone promotes degradation of key proteins in the innate immune signaling to suppress inflammation
    Murugan S, Jakka P, Namani S, et al. · The Journal of biological chemistry · 2019 · 被引 74cited 74

合成与制备工艺专利Synthesis & process patents

  1. EFFICIENT PROCESSES FOR PREPARING STEROIDS AND VITAMIN D DERIVATIVES WITH THE UNNATURAL CONFIGURATION AT C20 (20 ALPHA-METHYL) FROM PREGNENOLONE
    BRIDGES ALEXANDER J · 公开号 WO2008089093WO2008089093 · 2008
  2. Efficient Process for Preparing Steroids and Vitamin D Derivatives With the Unnatural Configuration at C20 (20 Alpha-Methyl) from Pregnenolone
    BRIDGES ALEXANDER JAMES · 公开号 US2008171728US2008171728 · 2008
  3. Use of 3-methoxy-pregnenolone for the preparation of a drug for treating depressive disorders and long-term neurological diseases
    BAULIEU ETIENNE-EMILE, FELLOUS ESTER, ROBEL PAUL, BIANCHI MASSIMILIANO · 公开号 US2009143347US2009143347 · 2009
  4. Pregnenolone in steroid species and isomeric compound in application of preparing medicaton for treating high blood pressure
    ZHAO HUA · 公开号 CN1539423CN1539423 · 2004
  5. NUCLEIC ACID SEQUENCE ENCODING PROTEIN ELICITING DELTA-5,7-STEROL,DELTA-7 REDUCTASE ACTIVITY (VARIANTS), PROTEIN FROM ARABIDOPSIS THALIANA ELICITING INDICATED ACTIVITY (VARIANTS), EXPRESSION VECTOR, METHOD FOR CLONING NUCLEIC ACID, DIAGNOSTIC PROBE, METHOD FOR PREPARING PROTEIN, METHOD FOR REDUCING STEROL (VARIANTS), METHOD FOR PREPARING PREGNENOLONE (VARIANTS), TRANSFORMED YEAST STRAIN AND METHOD FOR DETECTING INSUFFICIENCY OF DELTA-5,7-STEROL,DELTA-7 REDUCTASE
    SHENIVES KSAV E, DJUPOR KATRIN, LEKEHN EHRIK, POMPON DENI · 公开号 RU2242517RU2242517 · 2004

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

孕烯醇酮 杂质谱研究要点Pregnenolone — impurity profiling notes

下面这些是拿到 孕烯醇酮 的 23 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 23 impurity entries for Pregnenolone, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances